Trial intelligence / Profile preview

Effect of Increased Circulating Androgens on Granulosa Cell Responses to FSH in PCOS

NCT02389088Completed

Sponsor
University of California, San Diego
Start
Apr 2006
Primary completion
Jan 2013
Modality
Orthosteric Ligands
01

Overview

Open-label trial of letrozole in polycystic ovary syndrome (PCOS) (2 arms), sponsored by University of California, San Diego. Primary endpoints: Estradiol Levels at Week 6, Inhibin B Levels at Week 6 and 2 more. Started Apr 2006; status: completed.

02

Drugs

letrozole
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT02389088.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02389088.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call